Philips has received the US Food and Drug Administration (FDA) 510(k) clearance of remote scanning and protocol management capabilities on Radiology Operations Command Center (ROCC).
This approval facilitates on-the-spot assistance from expert radiologists to technologists.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
ROCC, a multi-vendor and multi-modality imaging solution, is already widely utilised across North America and Europe.
Compatible with any magnetic resonance (MR) or computerised tomography (CT) system, it connects imaging experts in a central command centre with technologists at various locations within an organisation.
A pilot study conducted at Imperial College Healthcare NHS Trust in London reported a 9% rise in scanning throughput and no exam recalls, highlighting the efficiency of ROCC.
Philips Business Leader Patient Care Informatics Shiv Gopalkrishnan said: “Healthcare providers are increasingly confronted with the challenge of not having enough skilled technologists to meet the demand for patient imaging exams, particularly for more complex exams such as cardiac MR.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData“With the 510(k) clearance of ROCC’s remote scanning and remote protocol management capabilities, we are further empowering clinicians to deliver the timely diagnosis that patients deserve and helping to deliver better care for more patients.”
With the newly cleared remote scanning capabilities of ROCC, experts will be able to modify MR and CT scanner consoles from any location in real time.
This feature is complemented by on-demand chat, voice, and video collaboration tools that do not compromise privacy or security.
Philips is set to demonstrate the ROCC at the upcoming Radiological Society of North America Annual Meeting taking place from 1 to 4 December 2024, in Chicago, US.
The company will also unveil its next-generation BlueSeal 1.5T MRI system at the meeting.
